Asset 1

Healthtech & Digital health

Our tech and life sciences teams provide seamless expert advice for global companies and investors in the fast-growing digital health industry. Our clients are renowned investors, from prominent early-stage funds to the largest global venture capital firms, and ambitious global digital health companies who, with our support, are revolutionizing the industry.

Through our established investor network we create transformative funding solutions for clients at all business stages, creating substantial financial foundations for growth and on-going development.

With experts in the UK, Europe, the Middle East, and Asia, together with our key partner collaborations in the US, our specialist approach in the provision of finance and capital raising, regulatory and data privacy, and IP, coupled with cross border expertise, provides the foundations for significant and sustainable global expansion for our clients. Our comprehensive awareness of the regulatory challenges facing emerging digital health companies both internally, and among ecosystem partners, is invaluable.

Supported by our data privacy and security teams, we successfully resolve personal data issues particular to digital and app-based devices and the broader regulatory challenges faced by our clients within a rapidly changing industry.

Similarly, our highly regarded IP team helps digital health companies achieve important milestones by securing, developing, and protecting valuable IP assets. This includes restructuring and executing sophisticated agreements and collaborations, partnerships and licensing agreements, and acquiring and divesting valuable businesses through strategic M&A.

Protection des données et cybersécurité

Defining and using health data

31 janvier 2022

par Victoria Hordern

Cliquer ici pour en savoir plus
Intelligence artificielle et machine learning

Artificial Intelligence Act (AIA) - Legal uncertainty for medical device manufacturers

30 novembre 2021
Briefing

par Dr. Daniel Tietjen et Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

Cliquer ici pour en savoir plus
e-santé

Digitisation in hospitals: Data protection as an obstacle or opportunity in Germany?

24 novembre 2021
Briefing

par Mareike Christine Gehrmann et Dr. Carolin Monsees

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Cambridge Epigenetix on its $88 million Series D funding round to advance best-in-class DNA sequencing technology platform

2 novembre 2021

par Ross McNaughton et Oli Denne

Cliquer ici pour en savoir plus

Événements connexes